🩸 Theranos — A $9 Billion Valuation Built on a Machine That Didn't Work

Elizabeth Holmes was, on paper, the youngest self-made female billionaire in America. The technology behind that valuation was largely fiction — and because this was a medical-testing company, the fabrication put real patients' health decisions at risk, not just investor money. A jury convicted her; an appeals court upheld it.

🔬 AMS Core Frame

Most fraud on this site is about money moving somewhere it shouldn't. This one is different in kind: the product itself was the fraud, and the product was blood tests people used to make real medical decisions. Deleting inconvenient results to make a machine look accurate isn't a financial technicality — it's fabricating the thing a patient's doctor might act on.

A fingerprick that was supposed to replace the blood draw

2003

Year Elizabeth Holmes founded Theranos, at age 19

$9B

Theranos's peak valuation, reached in the early-to-mid 2010s

2015

Forbes names Holmes the youngest self-made female billionaire in the US, on paper

$140M+

Investor funds involved in the wire transfers underlying her fraud convictions

FACT

Theranos claimed to have developed proprietary technology that could run comprehensive blood tests using only a small fingerprick sample, instead of a standard venous blood draw. The claim drove the company to a $9 billion valuation and made Holmes, on paper, the youngest self-made female billionaire in the US as of 2015.

FACT

In October 2015, a Wall Street Journal investigation revealed that Theranos had, in reality, largely repurposed commercially available blood-analysis machines to try to process smaller sample volumes — not the proprietary technology it had marketed.

📮 Worked somewhere that shipped results it knew weren't reliable?

If you've seen a company hide product failures behind investor-facing metrics, especially in health or safety-critical products, you can submit a tip anonymously.

Submit a tip →